At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 60 enrolled
Drug / intervention
acamprosate +1 moredrug
Likely dose
acamprosate 1998 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase II, Double-Blind, Placebo-controlled, Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence
In Brief
A Phase 2 clinical trial evaluating acamprosate and placebo for Cocaine Dependence. Completed, enrolled 60 participants across 1 site.
Detailed Summary
Trial to determine the safety, efficacy and tolerability of acamprosate for the treatment of cocaine dependence.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCocaine Dependence
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)
Timeline
Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 2006
Enrollment StartNov 2006
Primary CompletionMay 2008
Study CompletionJul 2008
TodayJul 2026
First PostedOct 9, 2006
Enrollment StartNov 1, 2006
Primary CompletionMay 1, 2008
Study CompletionJul 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 19.7 years ago
Interventions
acamprosatedrug
1998 mg/dau fpr 8 weeks
placebodrug
placebo pills